Answers are grounded in this paper and cite their sources.
The Intravascular Surveillance Nanobot Mark II (ISN-02) is a theoretical research whitepaper advancing biomedical nanorobotics. Building upon the ISN-01 baseline architecture (DOI: 10.5281/zenodo.24212884), this framework introduces zwitterionic pCBMA ultra-low fouling hydration brushes, thrombomodulin-mediated thromboresistance, Skalak-compliant hyperelastic microcapillary deformation, Angiopep-2 LRP-1 receptor-mediated blood-brain barrier transcytosis, continuous enzymatic glucose-biofuel cell (GBFC) power generation (388 pW), and an expanded 8-plex neuro-cardiovascular GFET biosensor array. Predecessor Foundation: ISN-01 Baseline Architecture (DOI:10.5281/zenodo.24212884)
No takes yet. Share an insight, caveat, or question.
Kallu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: